History
  • No items yet
midpage
Gill-Samuel v. Nova Biomedical Corp.
298 F.R.D. 693
S.D. Fla.
2014
Read the full case

Background

  • Plaintiff Robin Gill-Samuel sued Nova Biomedical after a July–August 2013 voluntary recall of Nova Max glucose test strips alleged to report falsely high blood-glucose readings; she alleges unnecessary medical treatment following a falsely high reading.
  • Plaintiff seeks to represent a class of all purchasers of recalled strips and a subclass of purchasers who incurred medically related expenses due to improper readings.
  • Nova moved to dismiss under Rule 12(b)(6), arguing the economic-loss rule bars the tort claims and that the complaint fails to meet Twombly/Iqbal pleading standards; Nova also moved to strike the class-action allegations under Rule 12(f).
  • The court stayed discovery pending resolution of the motions but found striking class allegations more final and less flexible than ordinary Rule 23 practice, so applied the stricter Rule 12(f) lens while considering Rule 23 factors.
  • The court dismissed the broad class of all purchasers to the extent their claims assert only product damage (economic loss), but allowed (1) Plaintiff’s individual tort claims to proceed and (2) the subclass of purchasers who incurred additional medically-related expenses to remain.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether the economic-loss rule bars Plaintiff’s tort claims Gill-Samuel: tort claims valid because she suffered additional harm (unnecessary medical treatment) beyond product loss Nova: economic-loss rule precludes tort recovery for purely economic/product-only losses Court: individual tort claims and subclass alleging medical expenses allowed; class limited to purchasers asserting only product damage dismissed under economic-loss rule
Whether complaint meets Rule 8/Twombly-Iqbal pleading standard Gill-Samuel: complaint alleges she purchased defective strips and received unnecessary medical treatment; facts suffice Nova: complaint lacks lot specificity, details of medical treatment, and proof strips were defective Court: complaints’ nonconclusory allegations accepted as true; motion to dismiss for failure to state a claim denied
Whether class-action allegations should be struck under Rule 12(f) Gill-Samuel: class allegations are proper and not redundant/impertinent Nova: class allegations facially defective and should be struck before class discovery Court: striking is drastic; allegations not immaterial/impertinent/scandalous; motion to strike denied (Rule 12(f) standard applied)
Proper standard to address motion to strike class allegations Gill-Samuel: Rule 23 certification should await a motion for certification and discovery Nova: court should address class defects now (urge Rule 23 analysis) Court: applied Rule 12(f) to decide whether allegations are redundant/impertinent while viewing Rule 23 factors; denied strike but dismissed product-only class under economic-loss doctrine

Key Cases Cited

  • Ashcroft v. Iqbal, 556 U.S. 662 (2009) (pleading standard requires more than legal conclusions)
  • Bell Atl. Corp. v. Twombly, 550 U.S. 544 (2007) (complaint must state a plausible claim)
  • Tiara Condo. Ass’n, Inc. v. Marsh & McLennan Cos., 110 So.3d 399 (Fla. 2013) (economic-loss rule applies to product-liability cases and limits tort recovery for disappointed economic expectations)
  • Wal-Mart Stores, Inc. v. Dukes, 564 U.S. 338 (2011) (Rule 23(a) prerequisites: numerosity, commonality, typicality, adequacy)
  • Hughes v. Lott, 350 F.3d 1157 (11th Cir. 2003) (on motion to dismiss, court accepts nonconclusory allegations as true)
Read the full case

Case Details

Case Name: Gill-Samuel v. Nova Biomedical Corp.
Court Name: District Court, S.D. Florida
Date Published: Apr 8, 2014
Citation: 298 F.R.D. 693
Docket Number: No. 13-62591-CIV
Court Abbreviation: S.D. Fla.